Treatment strategy of Lewy body disease by activation of intracellular degradation system
Description: The accumulation of mis-folded and/or abnormally modified proteins is a major characteristic of many neurodegenerative diseases. In Lewy body disease (LBD), insoluble α-synuclein is widely deposited in the presynaptic terminals as well as in the neuronal cytoplasm in distinct brain regions. The autophagy-lysosome system is an efficient degradation pathway for abnormal molecules within cells. We investigated the effect of trehalose on abnormal aggregation of α-synuclein in a model of LBD. Trehalose treatment induced autophagy and reduced level of detergent-insoluble α-synuclein, although an apparent alteration was not observed in abnormal aggregation of α-synuclein. These results indicate that the oral intake of trehalose can be a promissing treatment for prevention of accumulation of abnormal α-synuclein, especially before aggregation formation.
Amount: ¥2,990,000
Funding type: fellowship
Funder scheme: Grant-in-Aid for Young Scientists (B)
Start date: 2014-04-01
End date: 2016-03-31
Investigator: Yasuo Miki (lead)
Institution: Hirosaki University
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 12
Funder award ID: 26860655
OpenAlex ID: G2014468658
